(Q27853222)

2

0 references

Li-Li Wang

3

0 references

Lu-Tao Du

4

0 references

Yong-Mei Yang

5

0 references

Juan Li

6

0 references

Chuan-Xin Wang

7

0 references

language of work or name

English

0 references

publication date

December 2015

0 references

published in

Carcinogenesis

0 references

volume

36

0 references

issue

12

0 references

page(s)

1484-93

0 references

cites work

Cancer trends in China

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Systemic therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

In vitro studies on the mechanisms of oxaliplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Adaptation to oxidative stress, chemoresistance, and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Glutathione transferases and development of new principles to overcome drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Role for a bidentate ribonuclease in the initiation step of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

microRNAs exhibit high frequency genomic alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

MicroRNAs MiR-218, MiR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Targeting survivin in cancer: the cell-signalling perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Inhibitory effect of biosynthetic nanoscale peptide Melittin on hepatocellular carcinoma, driven by survivin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

Thymidylate synthase inhibitors as anticancer agents: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV145

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGV145

1 reference

Consolidated OpenCitations Corpus – April 2017

2280606

2280606

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference